Construction and Validation of a Newly Prognostic Signature for CRISPR-Cas9-Based Cancer Dependency Map Genes in Breast Cancer

Figure 5

Validation for the prognostic value of the constructed risk model along with different clinical characteristics. Univariate (a) and multivariate (c) COX regression analysis of the signature and different clinical features in the TCGA training set. Univariate (b) and multivariate (d) COX regression analysis of the signature and different clinical features in the TCGA testing set.

(a)

(b)

(c)

(d)